731
Views
29
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

H2AX a Promising Biomarker for Lung Cancer: A Review

, , , &
Pages 582-599 | Published online: 28 Oct 2013
 

Abstract

Histone's H2A variant (H2AX) phosphorylation is an early indicator of DNA double-strand breaks formation and DNA damage response. Thus, it may act as a novel biomarker to monitor genotoxic events that can drive cancer development and tumor progression. This review will focus on the possible applications of H2AX as a key regulator of DNA damage response in lung cancer and as a biomarker of: sensitivity of lung tumors to chemotherapy and radiotherapy, treatment with PARP inhibitors, bystander effect, multistep lung carcinogenesis, environmental smoking, and chemical genotoxicity, chemoprevention, prognosis, and also as therapeutic targets in lung cancers.

ABBREVIATIONS
NSCLC=

non-small cell lung cancer

DSB=

double strand breaks

DDR=

DNA damage response

SCC=

squamous cell carcinoma

AIS=

adenocarcinoma in situ

ADC=

invasive adenocarcinoma

NHEJ=

Non-Homologous End Joining

SCLC=

Small Cell lung carcinoma

ROS=

reactive oxygen species

HR=

homologous recombination

PFGE=

pulse-field gel electrophoresis

SCGE=

single cell gel electrophoresis

CTCs=

Circulating tumor cells

CACD=

computer-aided cytologic diagnosis

FACS=

Fluorescence Activated Cell Sorting

RABIT=

Rapid Automated Biodosimetry Tool

BG=

O6-Benzylguanine

NER=

nucleotide excision repair

EGCG=

Epigallocatechin-3-gallate

CSS=

cigarette sidestream smoke

OA=

obtusilactone A

NPR2=

NPR2 nitrogen permease regulator 2

PRXV=

Peroxiredoxin

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.